USPTO trademark

BREAKTHROUGH T1D CLINICAL & RESEARCH CONGRESS

AllowedUSPTOWord markClass 41

"BREAKTHROUGH T1D CLINICAL & RESEARCH CONGRESS" is a word mark owned by Breakthrough T1D, filed at the USPTO on July 18, 2025. It has been allowed and covers class 41 (Education and Entertainment).

View Breakthrough T1D portfolioGet this data via the API
Official USPTO record
BREAKTHROUGH T1D CLINICAL & RESEARCH CONGRESS trademark as filed
As filed with the USPTO
Status
Allowed
Since August 3, 2026
Filed
July 18, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99291755
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns BREAKTHROUGH T1D CLINICAL & RESEARCH CONGRESS

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Breakthrough T1D

New York, United States

97 trademarks in the portfolioView company

Representative

Emily R. Billig

Baker, Donelson, Bearman, Caldwell & Berkowitz, A Professional Corporation

Goods and services

What the mark covers

The products and services BREAKTHROUGH T1D CLINICAL & RESEARCH CONGRESS is filed for, grouped by Nice class.

  • Arranging and conducting of conferences and congresses in the field of diabetes research; Arranging and conducting of educational conferences and congresses in the field of diabetes; Arranging and conducting of conferences and congresses in the field of advocacy regarding public awareness of diabetes, diabetes research, and treatments, preventions and cures for diabetes

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of approval of extension request e-mailed
  2. Sou extension 1 granted
  3. Sou extension 1 filed
  4. Sou teas extension received
  5. Noa e-mailed - sou required from applicant
  6. Official gazette publication confirmation e-mailed
  7. Published for opposition
  8. Notification of notice of publication e-mailed
  9. Approved for pub - principal register
  10. Teas/email correspondence entered

9 earlier steps on the official record.

FAQ

About BREAKTHROUGH T1D CLINICAL & RESEARCH CONGRESS

Who owns the trademark "BREAKTHROUGH T1D CLINICAL & RESEARCH CONGRESS"?

The USPTO trademark "BREAKTHROUGH T1D CLINICAL & RESEARCH CONGRESS" (application 99291755) is owned by Breakthrough T1D.

What is the status of "BREAKTHROUGH T1D CLINICAL & RESEARCH CONGRESS"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull BREAKTHROUGH T1D CLINICAL & RESEARCH CONGRESS and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2afb-5e0f-72f2-8b4c-39b65e670006
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2afb-5e0f-72f2-8b4c-39b65e670006",
  "object": "trademark",
  "mark_text": "BREAKTHROUGH T1D CLINICAL & RESEARCH CONGRESS",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99291755",
  "filing_date": "2025-07-18",
  "nice_classes": [
    41
  ],
  "owners": [
    {
      "name": "Breakthrough T1D",
      "entity_id": "ent_01a10e20-ceef-759b-b5c4-86dd43f60b1d"
    }
  ]
}